Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 11
Geneuro Enters into Agreement with National Institute of Neurological Disorders and Stroke 12
Thrombolytic Science Enters into Agreement with National Institute of Neurological Disorders and Stroke 13
Lixte Biotech Enters into R&D Agreement with National Institute of Neurological Disorders and Stroke 14
Licensing Agreements 15
Cogentis Therapeutics to Enter into Licensing Agreement with National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services 15
National Institute of Neurological Disorders and Stroke – Key Competitors 16
National Institute of Neurological Disorders and Stroke – Key Employees 17
National Institute of Neurological Disorders and Stroke – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Government and Public Interest 19
Nov 06, 2017: The Wistar Institute Awarded More Than $16.5M in Grants to Fund Cancer & Infectious Disease Research and Training 19
Oct 31, 2017: NIH: Study shows how memories ripple through the brain 21
Oct 26, 2017: Scientists find a role for Parkinson’s gene in the brain 22
Oct 23, 2017: Penn Radiology Researcher Awarded $3.9 Million to Help Develop First Three-Dimensional Digital Atlas of Brain Cells 23
Oct 18, 2017: New insight into how brain cells die in Alzheimer’s disease and FTD 24
Oct 02, 2017: CU Researchers win prestigious $2 million NIH grant for brain study 26
Sep 20, 2017: Immune cells may heal bleeding brain after strokes 27
Sep 07, 2017: NIH awards nearly $100 million for Autism Centers of Excellence program 29
Aug 18, 2017: Nortis Awarded $688K NIH Phase II SBIR Fast Track Grant to Develop Living Model of Human Blood-Brain Barrier 31
Aug 15, 2017: New $1.9M federal grant to fund JAX studies of microbiome’s role in multiple sclerosis 32
Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 33
Jun 21, 2017: Researchers uncover genetic gains and losses in Tourette syndrome 35
Jun 20, 2017: BlackThorn Therapeutics to Receive Up to $8 Million in NIH Blueprint Neurotherapeutics Network Funding to Advance Kappa Opioid Receptor Antagonist Program 36
Jan 26, 2017: NIH initiates pilot grant program for innovative neurological research 37
Dec 01, 2016: Castro Announces $5.29M for UTSA Brain Health Research 41
Oct 13, 2016: Recombinetics Awarded Two NIH Grants to Develop Humanized Swine Models of Alzheimer’s Disease and Neurofibromatosis 2 42
Oct 07, 2016: Researchers find novel function for old protein in work that could lead to new ways to protect brain from stroke damage 43
Aug 10, 2016: NIH-funded study supports surgery as treatment for myasthenia gravis 44
Apr 07, 2016: Publication highlights release of muscular dystrophy action plan 46
Mar 07, 2016: Eye cells may use math to detect motion 47
Feb 18, 2016: Surgery and stenting safe, effective lowering long-term risk of stroke 48
Feb 18, 2016: NIH-supported trials test hormonal therapy in older men with low testosterone levels 49
Feb 15, 2016: Mind-Controlled Prosthetic Arm Moves Individual ‘Fingers’ 50
Product News 52
Jun 24, 2016: Manufactured stem cells to advance clinical research 52
Other Significant Developments 53
Feb 04, 2016: New members selected for National Advisory Neurological Disorders and Stroke Council 53
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Key Facts 2
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
National Institute of Neurological Disorders and Stroke, Deals By Therapy Area, 2011 to YTD 2017 9
National Institute of Neurological Disorders and Stroke, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 11
Geneuro Enters into Agreement with National Institute of Neurological Disorders and Stroke 12
Thrombolytic Science Enters into Agreement with National Institute of Neurological Disorders and Stroke 13
Lixte Biotech Enters into R&D Agreement with National Institute of Neurological Disorders and Stroke 14
Cogentis Therapeutics to Enter into Licensing Agreement with National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services 15
National Institute of Neurological Disorders and Stroke, Key Competitors 16
National Institute of Neurological Disorders and Stroke, Key Employees 17